Optimizing Ventilation to Improve Survival From Out-of-hospital Cardiac Arrest: the OPTIVO Randomized Controlled Trial

NCT07479836 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1656

Last updated 2026-03-18

No results posted yet for this study

Summary

When the heart stops pumping during cardiac arrest, cardiopulmonary resuscitation (CPR) is used to continue pushing blood and providing oxygen to vital organs. CPR involves a combination of chest compressions (to push the blood) and ventilations (to provide oxygen and gas exchange). There is a lot of research that has helped to optimize the provision of chest compressions, however there is considerably less research available to guide ventilations. The current guideline recommendations are based on limited data, and no data that is specific to cardiac arrest patients. There is a recognized need for research to better guide ventilation during CPR. This research will help to better define appropriate ventilation targets for cardiac arrest patients.

Conditions

  • Cardiac Arrest

Interventions

OTHER

Low Volume Ventilation

Patients in cardiac arrest will be ventilated with a volume of 350ml (+/- 50 ml)

OTHER

High Volume Ventilation

600ml (+/-50ml)

Sponsors & Collaborators

  • Zoll Medical Corporation

    collaborator INDUSTRY
  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Ian Drennan, PhD · Sunnybrook Health Sciences Centre

  • Sheldon Cheskes, MD · Sunnybrook Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2028-01-31
Completion
2028-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07479836 on ClinicalTrials.gov